These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 21622732)
1. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy. Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732 [TBL] [Abstract][Full Text] [Related]
2. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059 [TBL] [Abstract][Full Text] [Related]
3. Suramin inhibits renal fibrosis in chronic kidney disease. Liu N; Tolbert E; Pang M; Ponnusamy M; Yan H; Zhuang S J Am Soc Nephrol; 2011 Jun; 22(6):1064-75. PubMed ID: 21617121 [TBL] [Abstract][Full Text] [Related]
4. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250 [TBL] [Abstract][Full Text] [Related]
5. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling. You YK; Luo Q; Wu WF; Zhang JJ; Zhu HJ; Lao L; Lan HY; Chen HY; Cheng YX J Cell Mol Med; 2019 Aug; 23(8):5576-5587. PubMed ID: 31211499 [TBL] [Abstract][Full Text] [Related]
6. Delayed administration of suramin attenuates peritoneal fibrosis in rats. Xiong C; Liu N; Shao X; Sharif S; Zou H; Zhuang S BMC Nephrol; 2019 Nov; 20(1):411. PubMed ID: 31727005 [TBL] [Abstract][Full Text] [Related]
7. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Yang J; Liu Y Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273 [TBL] [Abstract][Full Text] [Related]
9. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway. Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017 [TBL] [Abstract][Full Text] [Related]
10. Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction. Le Y; Zheng Z; Xue J; Cheng M; Guan M; Xue Y J Renin Angiotensin Aldosterone Syst; 2016 Oct; 17(4):. PubMed ID: 27913661 [TBL] [Abstract][Full Text] [Related]
11. KS370G, a caffeamide derivative, attenuates unilateral ureteral obstruction-induced renal fibrosis by the reduction of inflammation and oxidative stress in mice. Chuang ST; Kuo YH; Su MJ Eur J Pharmacol; 2015 Mar; 750():1-7. PubMed ID: 25620133 [TBL] [Abstract][Full Text] [Related]
12. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Ishidoya S; Morrissey J; McCracken R; Klahr S Kidney Int; 1996 Apr; 49(4):1110-9. PubMed ID: 8691732 [TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats. Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438 [TBL] [Abstract][Full Text] [Related]
16. Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction. Liu C; Mei W; Tang J; Yuan Q; Huang L; Lu M; Wu L; Peng Z; Meng J; Yang H; Shen H; Lv B; Hu G; Tao L PLoS One; 2015; 10(6):e0129283. PubMed ID: 26042668 [TBL] [Abstract][Full Text] [Related]
17. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis. Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475 [TBL] [Abstract][Full Text] [Related]
18. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling. Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895 [TBL] [Abstract][Full Text] [Related]
19. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222 [TBL] [Abstract][Full Text] [Related]